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Background: Nikkomycins are competitive inhibitors of chitin synthase and inhibit the growth of filamentous fungi,
insects, acarids and yeasts. The gene cluster responsible for biosynthesis of nikkomycins has been cloned and the
biosynthetic pathway was elucidated at the genetic, enzymatic and regulatory levels.
Results: Streptomyces ansochromogenes ΔsanL was constructed by homologous recombination and the mutant
strain was fed with benzoic acid, 4-hydroxybenzoic acid, nicotinic acid and isonicotinic acid. Two novel nikkomycin
analogues were produced when cultures were supplemented with nicotinic acid. These two compounds were
identified as nikkomycin Px and Pz by electrospray ionization mass spectrometry (ESI-MS) and nuclear magnetic
resonance (NMR). Bioassays against Candida albicans and Alternaria longipes showed that nikkomycin Px and Pz
exhibited comparatively strong inhibitory activity as nikkomycin X and Z produced by Streptomyces ansochromogenes
7100 (wild-type strain). Moreover, nikkomycin Px and Pz were found to be more stable than nikkomycin X and Z at
different pH and temperature conditions.
Conclusions: Two novel nikkomycin analogues (nikkomycin Px and Pz) were generated by mutasynthesis with the
sanL inactivated mutant of Streptomyces ansochromogenes 7100. Although antifungal activities of these two
compounds are similar to those of nikkomycin X and Z, their stabilities are much better than nikkomycin X and Z
under different pHs and temperatures.
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Nikkomycins are a group of peptidyl nucleoside antibi-
otics produced by Streptomyces ansochromogenes [1] and
Streptomyces tendae [2]. Acting as competitive inhibitors
of chitin synthase, nikkomycins inhibit the growth of
filamentous fungi, insects, acarids and yeasts [3]. The
gene cluster responsible for biosynthesis of nikkomycins
has been cloned from S. ansochromogenes and S. tendae.
Biosynthesis of nikkomycins has been studied extensively
at the genetic, enzymatic and regulatory levels in both
Streptomyces strains [4-11].
Nikkomycins are composed of peptidyl and nucleo-
side moieties. The peptidyl moiety consists of 4-(4′-
hydroxy-2′-pyridinyl)-homothreonine (HPHT) while
the nucleoside moiety varies in different nikkomycins* Correspondence: niugq@im.ac.cn; tanhr@im.ac.cn
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unless otherwise stated.(Figure 1A). Previous studies demonstrated that a L-
lysine 2-aminotransferase catalyzes the initial reaction
from L-lysine to piperideine-2-carboxylate (P2C) in HPHT
formation [9]. A monomeric sarcosine oxidases was found
to be responsible for the conversion of P2C to picolinic
acid, which was activated by a picolinate-CoA ligase to
continue subsequent reactions [4,10].
Mutasynthesis has become a useful method in the gen-
eration of new antibiotic derivatives. It can be started by
blocking the biosynthesis of key biosynthetic intermedi-
ates, and a variety of alternative intermediates can then
be fed to the mutant to produce novel antibiotic deriva-
tives [12]. This approach could expand the chemical di-
versity of antibiotics and produce novel compounds with
improved pharmaceutical properties [13,14].
Here we described the mutasynthesis of nikkomycins
Px and Pz by feeding S. ansochromogenes ΔsanL with
analogues of picolinic acid. Supplementation of the
mutant strain with nicotinic acid led to production of twod. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Chemical structure (A) and organization of the gene cluster for nikkomycin biosynthesis (B). The peptidyl moiety (HPHT) and
nucleoside moiety of nikkomycin were indicated by blue color and red color, respectively. The solid arrow shows sanL and its orientation. The
2.1 kb BglII/BstXI fragment contains sanL and its flanking sequences. The 3.1 kb BglII/BstXI fragment was used for disruption of sanL. The
kanamycin resistance gene (neo) was inserted into BclI site of sanL.
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properties.
Results
Construction of sanL inactivation mutant and its
complementation
Mutasynthesis requires the generation of mutants that
are blocked in the formation of key biosynthetic
intermediate of the end-product. For this purpose, we
inactivated sanL by double-crossover recombination in
S. ansochromogenes 7100 (Figure 1B). Sequence analysis
revealed that sanL encodes a L-lysine 2-aminotransferase
which showed 97% identity with NikC from S. tendae. The
disruption of sanL was confirmed by PCR and Southern
blot (data not shown). The resulting inactivated mutant
was subjected to HPLC analysis to assess nikkomycin pro-
duction. In comparison with nikkomycin production in the
wild-type strain, no nikkomycin was detected in the fer-
mentation medium of sanL mutant (ΔsanL) (Figure 2A).
To test the antifungal activity of ΔsanL strain, the culture
filtrates of ΔsanL and wild-type strains were subjected to
bioassays against C. albicans and A. longipes. Culture fil-
trate of ΔsanL lost the ability to inhibit the growth
of C. albicans and A. longipes (Figure 2B and C). Because
sanL is situated within a group of 7 genes that form an
operon, inactivation of downstream genes by polar effects
on transcription might have contributed to the pheno-
type observed. To exclude this possibility, the ΔsanL
strain was complemented by pSET152::sanL in which a
single copy of sanL was driven by the constitutive hrdBpromoter. The resulting complementation strain (sanLc)
restored nikkomycin production (Figure 2A) and its anti-
fungal activities (Figure 2B and C).
Feeding of ΔsanL strain with analogues of picolinic acid
Previous studies suggested that the picolinate-CoA ligase
had broad substrate specificities in accepting picolinic
acid and its analogues [4]. Cultures of ΔsanL strain were
fed with 1 mM analogues of picolinic acid (benzoic acid,
4-hydroxybenzoic acid, nicotinic acid and isonicotinic
acid). Cultures supplemented with benzoic acid pro-
duced nikkomycin Bx and Bz, which are consistent with
the results from S. tendae nikC mutant [15]. When the
cultures were supplemented with nicotinic acid, culture
filtrates of ΔsanL strain regained the ability to inhibit
the growth of C. albicans and A. longipes like the wild-
type and complementary strains (Figure 2B and C).
HPLC analysis revealed two distinct peaks at retention
time 18.5 and 19.5 min (Figure 2A). In contrast, no obvi-
ous peak was detected at corresponding retention time
in cultures supplemented with 4-hydroxybenzoic acid
and isonicotinic acid except for a minor peak at reten-
tion time 22.2 min (Figure 2A). Bioassay was detected
against C. albicans and A. longipes, no inhibition zone
was observed (Figure 2B and C).
Isolation and bioactive assay of nikkomycin Px and Pz
In order to characterize the compounds responsible for
antifungal activity, we isolated and purified them from
3 L broth of ΔsanL strain in fermentation tank. The two
Figure 2 HPLC analysis and bioassay of nikkomycin Px and Pz. HPLC analysis of fermentation broth from S. ansochromogenes 7100 and its
derivatives (A) and bioassays of nikkomycin production against C. albicans (B) and A. longipes (C). WT: S. ansochromogenes 7100, ΔsanL: sanL
disruption mutant, sanLc: sanL complementary strain, NA: nicotinic acid, HBA: 4-hydroxybenzoic acid, isoNA: isonicotinic acid, X: nikkomycin X, Z:
nikkomycin Z, Px:nikkomycin Px, Pz: nikkomycin Pz.
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powders, soluble in water but insoluble in ethanol, ether,
ethyl acetate, methanol and acetone. When the com-
pounds were dissolved in 0.1% trifluoroacetic acid (TFA)
solution, nikkomycin Px and Pz showed maximum ultra-
violet absorption at 290 nm and 260 nm, respectively
(Figure 3A, B, C and D). In addition, the yields of two com-
pounds were determined. It showed that ΔsanL strain sup-
plemented with nicotinic acid can produce nikkomycin Px
and Pz at 84 mg/L and 122 mg/L, respectively. The yield of
nikkomycin Pz is close to that of nikkomycin Z (120 mg/L)
in the wild-type strain, whereas the yield of nikkomycin Px
is lower than that of nikkomycin X (220 mg/L) in the wild-
type strain [16]. To compare their antifungal activities,
five micrograms of each compound (nikkomycin X, Z,
Px and Pz) were tested against C. albicans and A. longipes.
Both nikkomycin Px and Pz exhibited comparatively strong
inhibitory activity as nikkomycin X and Z produced by the
wild-type strain (Figure 3E and F).Structural determination of nikkomycin Px and Pz
Structure modeling analysis indicated that nikkomycin
Px and Pz may be new members of nikkomycin family
incorporated with the supplemented substrate precursor,
nicotinic acid, in the molecules. This assumption was
further validated by electrospray ionization mass spec-
trometry (ESI-MS) and nuclear magnetic resonance spec-
troscopic (NMR) analysis.
For nikkomycin Pz (Figure 4A), ESI-MS revealed an
[M + H]+ ion at m/z 480.2 and a mass of 16 lower than
nikkomycin Z, which are consistent with nikkomycin Z
lacking a hydroxyl group from the pyridine ring. Mo-
lecular formula was subsequently established to be
C20H25N5O9 (exact mass 479.2 Da) according to tandem
mass spectrometry (MS/MS) and NMR data. By compar-
ing 1H-NMR (Figure 4B) and 13C-NMR (Figure 4C) data
to those of nikkomycin Z, 1H and 13C chemical shifts in
nucleoside and homothreonine moieties were assigned
(Table 1). A set of distinctive proton signals: δ8.68 (1H, s),
Figure 3 Identification of nikkomycin Px and Pz. UV spectrum of nikkomycin Pz and Px with an absorption maximum at 260 nm (A) and
290 nm (B). HPLC analysis of purified nikkomycin Px (C) and Pz (D). Bioassays of nikkomycin Pz and Pz against C. albicans (E) and A. longipes (F).
X: nikkomycin X, Z: nikkomycin Z, Px:nikkomycin Px, Pz: nikkomycin Pz.
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δ8.60 (1H, d, 5.7Hz) suggested the difference in pyridine
ring. According to coupling constants (J) (Table 1), 1H-1H
COSY (Additional file 1: Figure S1A) and 1H-13C HSQC
data (Additional file 1: Figure S1B), it was concluded that
the pyridinyl ring attached to C-4 of homothreonine
(equivalent to C-4′′ in nikkomycin Pz) via meta-carbon.
To differentiate C-4′′′ and C-6′′′ chemical shift, 1H-13C
HMBC (Additional file 1: Figure S1C) was investigated.
The cross-peak between 13C signal at δ144.3 and H-4”
(δ5.36) suggested that the chemical shift of C-4′′′ andC-6′′′ is at δ144.3 and δ140.3 respectively. In summary,
the nucleoside moiety in nikkomycin Pz is identical with
that of nikkomycin Z, but the peptidyl moiety was de-
termined as 4-(3′-pyridinyl)-homothreonine (equivalent
to 4′′-(3′′′-pyridinyl)-homothreonine in nikkomycin Pz).
The chemical shifts of nikkomycin Pz were summarized
in Table 1.
For nikkomycin Px (Figure 5A), ESI-MS analysis re-
vealed the same fragmentation pattern as nikkomycin
Pz, indicating the structure similarity between these two
compounds. The molecular formula was determined as
Figure 4 Structural determination of nikkomycin Pz. (A) Structure of nikkomycin Pz. (B) 1H-NMR spectrum of nikkomycin Pz. (C) 13C-NMR
spectrum of nikkomycin Pz.
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NMR data. The identity of peptidyl and aminohexuronic
acid moieties in both nikkomycin Px and Pz was con-
firmed by 1H-NMR (Figure 5B), 13C-NMR (Figure 5C)
and 1H-1H COSY (Additional file 1: Figure S2A) data.
The comparison of NMR to those of nikkomycin X indi-
cated that the 4-formyl-4-imidazoline-2-one could be the
base of nucleoside moiety in nikkomycin Px. H-5 signal
at δ 5.74 in nikkomycin Pz disappeared in nikkomycinPx and consequently the doublet of H-6 (δ7.39, d, 8.1)
in Pz has changed to singlet (δ7.53, s) in nikkomycin
Px. A clear proton signal at δ9.16 (1H, s) and carbon
signal at δ180.3 in nikkomycin Px suggested an alde-
hyde group. 1H and 13C signals of the base group were
finally assigned by 1H-13C HSQC data (Additional file 1:
Figure S2B) and 1H-13C HMBC data (Additional file 1:
Figure S2C). The nucleoside moiety in nikkomycin Px was
corroborated as aminohexuronic acid with N-glycosidically
Table 1 Summary of 1H and 13C NMR data for nikkomycin
Px and Pz in D2O
Position Nikkomycin Px Nikkomycin Pz
δ (1H, mult., J) 13C (δ) δ (1H, mult., J) 13C (δ)
2 153.4 151.4
4 124.1 166.0
5 7.53 (1H, s) 125.5 5.74 (1H, d, 8.1) 102.4
6 9.16 (1H, s) 180.3 7.42 (1H, d, 8.1) 142.5
1´ 5.53 (1H, d, 4.5) 87.7 5.65 (1H, d, 4.2) 91.2
2´ 4.43 (1H, dd, 4.5, 5.5) 72.3 4.29 (1H, dd, 4, 6) 72.2
3´ 4.52 (1H, t, 5.5) 70.1 4.42 (1H, t, 6) 69.8
4´ 4.25 (1H, dd, 4.0, 5.5) 82.3 4.17 (1H, dd, 3.5, 6.5) 82.0
5´ 4.74 (1H, d, 4.0) 54.3 4.73 (1H, d, 4) 54.3
6´ 171.2 171.3
1´´ 168.9 168.9
2´´ 4.36 (1H, d, 4) 57.0 4.35 (1H, d, 4) 56.9
3´´ 2.36 (1H, m) 40.2 2.55 (1H, m) 39.6
4´´ 5.37 (1H, s) 71.3 5.36 (1H, s) 71.3
5´´ 0.68 (3H, d, 7) 5.11 0.67 (1H, d, 7.1) 5.05
2´´´ 8.7 (1H, s) 138.5 8.68 (1H, s) 138.6
3´´´ 142.8 142.7
4´´´ 8.49 (1H, d, 8.2) 144.4 8.46 (1H, d, 8.2) 144.3
5´´´ 7.97 (1H, dd, 8.1, 6) 127.1 7.94 (1H, dd, 8.1, 5.9) 127.1
6´´´ 8.62 (1H, d, 5.5) 140.3 8.60 (1H, d, 5.7) 140.3
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Thus, it was confirmed that nikkomycin Px shares the
same nucleoside moiety with nikkomycin X, but its pepti-
dyl moiety was determined as 4-(3′-pyridinyl)-homothreo-
nine (equivalent to 4′′-(3′′′-pyridinyl)-homothreonine in
nikkomycin Px). Chemical shifts of nikkomycin Px were
summarized in Table 1.
Stability of nikkomycin Px and Pz under different pHs
and temperatures
The stability of nikkomycin Px and Pz was performed.
They were more stable than nikkomycin X and Z at pH
from 4 to 10. Under acid conditions (pH4, 5 and 6), 60-
80% nikkomycin Px and Pz were present after 24 days of
incubation whereas only 0-20% nikkomycin X and Z
were remained (Figure 6A). Under neutral and alkaline
conditions (pH7, 8, 9 and 10), 40% nikkomycin Px and
Pz were present after 24 days of incubation while nikko-
mycin X and Z were completely degraded (Figure 6A).
No obvious instability of the four compounds was ob-
served at 10°C, but all of them became less stable with
increasing temperatures (Figure 6B). The stability of nik-
komycin Px and Pz is much better than that of nikkko-
mycin X and Z.Discussion
Owing to their low toxicity to mammals and bees, nik-
komycins are considered as competitive inhibitors of
chitin synthetases in fungi, insects, acarids and yeasts
[3]. During the past several decades, extensive studies
have been carried out to elucidate the biosynthetic path-
way of nikkomycins [4,7-11]. Based on prior knowledge,
novel nikkomycin analogues can be produced by gener-
ating mutant deficient in formation of biosynthetic inter-
mediates and subsequently feeding the mutant with a
variety of alternative intermediates.
Two novel nikkomycin analogues (nikkomycin Px
and Pz) were generated by supplementation of S. ansochro-
mogenes ΔsanL with nicotinic acid. Unlike nikkomycin X
and Z, nikkomycin Px and Pz contain 4-(3′-pyridinyl)-
homothreonine as the peptidyl moiety. As expected,
the position of nitrogen in the pyridinyl ring was
changed due to the difference between nicotinic acid
and picolinic acid. Surprisingly, the hydroxyl group is
absent in the pyridinyl ring of nikkomycin Px and Pz
(Figures 4A and 5A). Previous study in our lab dem-
onstrated that SanH and SanI are responsible for the
hydroxylation of pyridinyl residue in nikkomycin X
and Z [17]. The lack of the hydroxyl group in the pyr-
idinyl ring of nikkomycin Px and Pz indicated that
SanH and SanI are unable to recognize substrate with
3′-pyridinyl ring.
Antifungal activities of nikkomycin Px and Pz are simi-
lar to those of nikkomycin X and Z (Figure 2B and C).
This result indicated that incorporation of nicotinic acid
into the peptidyl moiety of nikkomycins has no effect on
their biological activities. However, nikkomycin Px and
Pz displayed better stabilities than nikkomycin X and Z
under different pHs and temperatures (Figure 6). This
was attributed to the combined effect of change of nitro-
gen position and loss of hydroxyl group in the pyridinyl
ring. Our results reinforced the proposal that the stabil-
ity of nikkomycins was influenced by the peptidyl moiety
of the compounds [15,18].
Conclusions
Two novel nikkomycin analogues (nikkomycin Px and Pz)
were generated by mutasynthesis with S. ansochromogenes
ΔsanL strain. Nikkomycin Px and Pz showed comparable
antifungal activity as nikkomycin X and Z. Moreover, they
also displayed better stabilities than nikkomycin X and Z
under different pHs and temperatures.
Materials and methods
Strains and culture conditions
Streptomyces ansochromogenes 7100 deposited at China
General Microbiological Culture Collection (CGMCC) is
a natural nikkomycin producer. Candida albicans and
Alternaria longipes from CGMCC were used as indicator
Figure 5 Structural determination of nikkomycin Px. (A) Structure of nikkomycin Px. (B) 1H-NMR spectrum of nikkomycin Px. (C) 13C-NMR
spectrum of nikkomycin Px.
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was used for propagating plasmids. E. coli ET12567
(pUZ8002) was used for conjugal transfer of DNA from
E. coli to Streptomyces [19].
Streptomyces strains were grown on R2YE medium,
mannitol soya flour (MS), minimal medium (MM) or
in yeast extract-malt extract (YEME) liquid medium
at 28°C. The culture conditions for nikkomycin pro-
duction were essentially as described previously [16].In brief, spore suspensions were inoculated in liquid
YEME and incubated at 28°C on a rotary shaker
(220 rpm) for 48 hr as seed culture. A total of 1 ml
seed culture was transferred into 100 ml SP medium
(3% mannitol, 1% soluble starch, 0.75% yeast extract,
and 0.5% soy peptone, pH 6.0) [20] for nikkomycin
production. When necessary, apramycin or kanamycin
was added at concentration of 50 μg/ml for R2YE,
7 μg/ml for MM and YEME.
Figure 6 Stability of nikkomycin Px(Pink circle), Pz(Green triangle), X(Black square) and Z(Blue diamond) under different pHs (A) and
temperatures (B). All samples were analyzed by HPLC and quantified according to the areas of peaks.
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For the construction of ΔsanL in S. ansochromogenes, a
2.1 kb BglII-BstXI DNA fragment containing complete
sanL was blunted and inserted into the EcoRV site of
pBluescript II KS(+). The resulting plasmid was linear-
ized with BclI and blunted with Mung bean nuclease.
The kanamycin-resistance gene (neo) was obtained from
pUC119::neo after digestion with BamHI and KpnI,
blunted and ligated into the blunted BclI site of sanL to
generate pBS-L::neo. A 3.1 kb insert of pBS-L::neo was
isolated after digestion with HindIII and EcoRI, and the
recovered fragment was then ligated into the same sitesof pKC1139. The resulting pKC1139L::neo was con-
firmed by restriction digestion and then introduced into
S. ansochromogenes 7100 by intergeneric conjugation
from E. coli ET12567 (pUZ8002) according to standard
techniques [21]. The resulting transformants were inoc-
ulated on agar MM to form spores. Gray spores were
harvested and spread on agar MM containing kanamy-
cin as resistance selection. After incubating at 40°C for
3 days, the sanL disruption mutants were selected with
colonies exhibiting kanamycin resistance (Kanr) and
apramycin sensitivity (Aprs). Kanr/Aprs strains were fur-
ther verified by PCR and Southern blot analysis. The
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ΔsanL.
For complementation experiments, the constitutive
hrdB promoter was used to drive the expression of sanL.
The hrdB promoter was amplified from genomic DNA
of Streptomyces coelicolor M145 with primers hrdB-pF/
hrdB-pR (5′-aattagatctCCGCCTTCCGCCGGAACG-3′;
5′-GAACAACCTCTCGGAACGTTGA-3′). The coding
region of sanL was amplified from genomic DNA of
S. ansochromogenes 7100 with primer pair sanL-cF/
sanL-cR (5′-ATGCTGACCGTGAACGGGAACTC-3′;
5′-attgaattcTCATGCCCGGGCCTCCTCG-3′). Prior to
PCR amplification, hrdB-pR was phosphorylated with T4
polynucleotide kinase to facilitate subsequent ligation re-
actions. The hrdB promoter fragment was digested with
BglII, and the sanL-coding region was digested with
EcoRI. Both the hrdB promoter and sanL-coding frag-
ment were ligated together with BamHI/EcoRI double-
digested pSET152. The resulting pSET152::sanL was
introduced into the ΔsanL strain to generate the comple-
mentation strain sanLc.
Detection of nikkomycins and antifungal bioassays
For the analysis of nikkomycin, culture broths were cen-
trifuged and the supernatants were filtered through a
millipore membrane (pore diameter 0.22 μm). HPLC
analysis was performed with Agilent 1100 HPLC system
and ZORBAX SB C-18 (5 μm, 4.6 × 250 mm). Chemical
reagent, mobile phase and gradient elution process were
as described previously [22]. The elution was detected
with photodiode array at 260 and 290 nm for nikkomy-
cins. Bioassays against C. albicans and A. longipes were
carried out by a disk diffusion method as described pre-
viously [5]. The procedure is essentially the same for
both indicator strains except that an overnight culture of
C. albicans was used while 5 day-old culture was used
for A. longipes. The modified potato dextrose agar
medium (20% potatoes, 2% glucose and 0.8% agar) was
heated to dissolve and then cooled to 50°C before use.
Cultures of indicator strains (50 μl for C. albicans and
10 ml for A. longipes) were well dispersed in 100 ml pre-
dissolved medium and poured to a 15 cm plate. Oxford
cups were placed onto the plates and antibiotics were
then added into the Oxford cups. After incubation for
12–24 h at 28°C, the zone of inhibition was assessed.
Isolation of nikkomycin Px and Pz
The method for isolation of nikkomycin Px and Pz was
similar to that for polyoxin P [23]. Briefly, seed culture
of S. ansochromogenes ΔsanL was prepared as mention
above. A total of 30 ml seed culture transferred into 3 L
SP supplemented with 1 mM nicotinic acid. After 5 days
of fermentation, the culture broth of S. ansochromogenes
ΔsanL was harvested by centrifugation and the supernatantwas adjusted to pH 4.5 with acetic acid. The sample was
then chromatographed on a macroporous absorption resin
HP-20 (Mitsubishi) column, and the flow-through was col-
lected and subjected to a Dowex 50WX2 (Sigma) column.
The column was eluted with 0.4 N ammonia solution and
fractions with antifungal activity was collected and concen-
trated to a small volume in vacuo. After addition of 6 vol-
umes of cold ethanol, the precipitate was collected by
centrifugation. The dried powder was subsequently dis-
solved in water and further purified by HPLC.
Stability determination of nikkomycin X, Z, Px and Pz
To dissect their stabilities under different pH conditions,
the four antibiotics (nikkomycin X, Z, Px and Pz) were
dissolved in buffers with different pH values: 0.2 M
CH3COONa buffer (pH adjusted to 4.0 or 5.0 with acetic
acid), 0.05 M KH2PO4 buffer (pH adjusted to 6.0 and 7.0
with NaOH), 0.05 M Tris buffer (pH adjusted to 8.0 with
HCl), 0.025 M Na2CO3 buffer (pH adjusted to 9.0 and
10.0 with NaOH). All samples were incubated at 25°C
for 27 days. To dissect the effect of temperature on their
stabilities, antibiotics were dissolved in 0.05 M KH2PO4
buffer (pH 6.0) and incubated at 10, 20, 30, 40 and 50°C
for 27 days. Residual antibiotics were quantified by the
peak areas.
Spectrometric analyses
MS analysis and tandem mass spectrometry analysis were
carried out on Triple-Quadrupole LC-MS/MS (Agilent
1260/6460) in positive mode. All NMR spectra were re-
corded on a Bruker Advance spectrometer (AV500 MHz).
Additional file
Additional file 1: Figure S1. NMR Spectra of nikkomycin Pz. (A) 1H-1H
COSY spectrum of nikkomycin Pz. (B) 1H-13C HSQC spectrum of nikkomycin
Pz. (C) 1H-13C HMBC spectrum of nikkomycin Pz. Figure S2. NMR Spectra of
nikkomycin Px. (A) 1H-1H COSY spectrum of nikkomycin Px. (B) 1H-13C HSQC
spectrum of nikkomycin Px. (C) 1H-13C HMBC spectrum of nikkomycin Px.
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